News | October 30, 2023
Dr Reddy's Q2 FY24 PAT jumps 33% to Rs 1,480 Cr
Dr Reddy’s Laboratories recorded revenue of Rs 6,880.20 crore during the quarter
Dr Reddy’s Laboratories recorded revenue of Rs 6,880.20 crore during the quarter
Apollo's unparalleled clinical excellence is built on extensive experience of performing over 300,000 angioplasties and 200,000 cardiac surgeries
Will continue to own a 7.84 per cent stake in Glenmark Life Sciences with the stake reduction
The market capitalization of the company stood at Rs. 7,000 crore +
Fillauer recently announced the launch of the first-ever bio-attributed prosthetic foot shell
Alleviating staff shortages by empowering surgeons with greater personalization and control
Low-leveraged balance sheets, sizeable liquidity to keep credit profiles stable
Sarah currently serves as the Chief Financial Officer and Principal Accounting Officer for Criteo S.A.
This collaboration marks a significant milestone in countering the disease burden by enhancing access to products for patients in the US
Amgen will be prohibited from leveraging its drug portfolio to disadvantage rivals and will be required to seek prior approval before acquiring related products
Subscribe To Our Newsletter & Stay Updated
